Importantly, this reduction in plasma HMGB1 was associated with reduced plasma NET levels (141.5% ± 38.1% vs. 233.7% ± 55.5%; Figure 6F) and greatly improved ischemic stroke outcomes (Figure 6, G–J). The gene discussed is HMGB1; the disease is ischemic stroke.